Exscientia

@exscientialtd

Exscientia is at the forefront of Artificial Intelligence-driven drug discovery and design

Oxford, UK
Vrijeme pridruživanja: rujan 2012.

Tweetovi

Blokirali ste korisnika/cu @exscientialtd

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @exscientialtd

  1. proslijedio/la je Tweet
    30. sij

    Last year I said I felt the biggest breakthroughs for AI in 2020 would be in Health. And then this.

    Poništi
  2. 30. sij

    We start 2020 with the first novel drug designed by entering human clinical trials. By the end of this new decade, we expect all drugs will be developed using AI. Read ’s piece about this critical milestone

    Poništi
  3. 30. sij

    We have reached a critical milestone in the development of and medicine. With Sumitomo Dainippon Pharma, we have developed the first drug created by to enter human clinical trials. Read more here:

    Poništi
  4. 21. sij

    Following a year of incredible growth, we’ve appointed Dr. David Hallett as our Chief Operating Officer and Head of Drug Discovery, responsible for delivering all of our drug discovery operations. Read more about David's extensive experience here:

    Poništi
  5. proslijedio/la je Tweet
    9. sij

    : and drug discovery company collaborate to accelerate the development of novel focusing on and :

    Poništi
  6. proslijedio/la je Tweet

    UK biotech company has signed a £204m tie-up with Bayer – the latest in a string of partnerships it has with pharma giants

    Poništi
  7. 9. sij

    A new decade and a significant addition to our roster of blue chip pharma and biotech partnerships: Our new deal with aims to harness the power of our AI platform to benefit patients with oncology and cardiovascular disease. Read more about it here:

    Poništi
  8. 6. sij

    Wonderful to see in list AI discovered drugs as the scientific breakthrough to expect in the 2020s. We are doing everything we can to make this a reality.

    Poništi
  9. 23. pro 2019.

    A 4th mention in is a great way to end 2019…read the piece by describing our "small data" approach and what we're looking forward to achieving in 2020

    Poništi
  10. proslijedio/la je Tweet
    21. stu 2019.

    "Knowledge is the efficiency of choice' – on the latest episode of the podcast Andrew Hopkins explains how this spark of wisdom inspired the very first drug development company

    Poništi
  11. 20. stu 2019.

    This year’s was supported by . We should all be texting NURSE to 70500 to donate £5 to help young people with cancer receive specialised nursing care and support.

    Prikaži ovu nit
    Poništi
  12. 20. stu 2019.

    We won! What a thrill. We definitely celebrated last night winning the Series B Finance Raise of the Year at the 2019 ! Thank you to the judges, organisers and as the category sponsor for recognising our efforts.

    Prikaži ovu nit
    Poništi
  13. 15. stu 2019.

    is poised to disrupt every part of the pharmaceutical industry value chain. Read how and Exscientia are changing the industry in 's latest report on - ‘Intelligent drug discovery. Powered by AI’

    Poništi
  14. 14. stu 2019.

    Didn’t get the chance to meet our CCO, Commercial Strategy Lead or Head of Target analysis at ? DM or email us to set up future a meeting

    Poništi
  15. 7. stu 2019.

    We will be in full force at BIO-Europe. Meet with Mark Swindells and Milly Chen for Commercial discussions and Dan Crowther for our latest AI-driven Chemistry and Biology advances. DM us to catch up at the Monday evening networking drinks.

    Poništi
  16. 7. stu 2019.

    The paradox of pharma is that better technology and more data has not halted declining productivity. Our hypothesis is that the one thing that has not kept up with the tsunami of data is the human cognitive bandwidth. can help solve this.

    Poništi
  17. 6. stu 2019.

    The future for drug discovery is here. Check out today’s fireside chat, with CEO Andrew Hopkins explaining how our unique approach of using is a superior way of discovering drugs. Now it’s just a matter of scaling this to the whole industry.

    Poništi
  18. 4. stu 2019.

    Find our CEO, Andrew Hopkins at the Deep-Tech stage , presenting how we’re using to alter the drug discovery landscape. To set up a meeting, feel free to drop Andrew and Georgy a message. Alternatively, you can find out more here:

    Poništi
  19. 1. stu 2019.

    Our platform delivers breakthrough productivity gains and has generated nearly 100 billion novel compounds through evolutionary design, to specifically explore the challenges in the development of bispecific small molecule drugs. Read more about our work in

    Poništi
  20. 31. lis 2019.

    We are currently seeking a highly motivated Finance Analyst/Associate to provide support and insights to the Head of Finance and CFO in running the day-to-day financial operations and setting the financial strategy for Exscientia.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·